首页> 外国专利> Immunotherapy using allo NKT cells and cells for which the α chain region of the T cell antigen receptor (TCR) gene is reconstituted into uniform Vα-Jα and banking of the cell-derived NKT cells

Immunotherapy using allo NKT cells and cells for which the α chain region of the T cell antigen receptor (TCR) gene is reconstituted into uniform Vα-Jα and banking of the cell-derived NKT cells

机译:使用同种异体NKT细胞和T细胞抗原受体(TCR)基因的α链区重构为均匀Vα-Jα的细胞进行免疫治疗并衍生细胞衍生的NKT细胞

摘要

The present invention relates to an NKT cell obtained by in vitro differentiation of a cell in which the α chain region of the T cell antigen receptor gene is reconstituted into a uniform Vα-Jα in an NKT cell receptor-specific manner. An immunocytotherapeutic agent, comprising the allogeneic individual that does not match the genotype of at least one of the MHC loci with the NKT cell, is provided. The present invention also provides a human cell or a bank of NKT cells derived from human cells in which the α chain region of the T cell antigen receptor (TCR) gene is reconstituted into a uniform Vα-Jα. The agent and cell bank of the present invention are useful for the prevention and / or treatment of cancer, infectious diseases, allergic diseases or autoimmune diseases.
机译:本发明涉及一种NKT细胞,该NKT细胞是通过以NKT细胞受体特异性方式将其中T细胞抗原受体基因的α链区域重构为均匀的Vα-Jα的细胞进行体外分化而得到的。提供了一种免疫细胞治疗剂,其包含与MHC基因座中至少一个的基因型与NKT细胞不匹配的同种异体个体。本发明还提供了衍生自人细胞的人细胞或NKT细胞库,其中T细胞抗原受体(TCR)基因的α链区被重构为均匀的Vα-Jα。本发明的试剂和细胞库可用于预防和/或治疗癌症,感染性疾病,过敏性疾病或自身免疫性疾病。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号